on September 23, 2002
Published online before print September 23, 2002, doi: 10.1161/01.CIR.0000033596.21845.D8
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 12, 2002
From the Department of Molecular and Cellular Pharmacology,
University of Miami School of Medicine, Miami, Fla (T.V.P.), and the
Departments of Pharmacology (E.A.S., E.P.A., P.D., M.R.R.) and
Pediatrics (M.R.R.) and the Center for Molecular Therapeutics (P.D.,
M.R.R.), College of Physicians and Surgeons of Columbia University, New
York, NY. * To whom correspondence should be addressed. E-mail: mrr1{at}columbia.edu.
Background—Recent clinical and experimental data suggest that testosterone may protect males against the deleterious effects of repolarization-prolonging drugs. This study tests the hypothesis that 5 Methods and Results—We used microelectrode techniques to study isolated preparations of rabbit ventricular endocardium from age-matched normal control female rabbits and female rabbits treated with DHT for 4 weeks. Serum 17ß-estradiol levels were identical in the control and DHT-treated animals, whereas DHT levels were high (equaling those in normal males) only in the DHT-treated animals. Basal action potential duration to 90% repolarization (APD90) was significantly shorter in DHT-treated (155±7.4 ms, n=32) than control females (178±6.7 ms, n=29; P<0.05) at cycle length=1000 ms. The increase in APD90 induced by 10-8 mol/L dofetilide at cycle length=1000 ms was significantly less in DHT-treated females than normal females ( Conclusions—Elevating DHT levels diminishes the effects of dofetilide to increase APD and induce early afterdepolarizations in females. Moreover, treatment of females with DHT results in prolongation of APD and an incidence of early afterdepolarization equal to values previously reported by us for dofetilide-treated normal males. That serum levels of 17ß-estradiol were the same in DHT-treated and untreated females suggests that estradiol is not involved in the response to dofetilide. Thus, these data suggest that DHT and perhaps other androgenic hormones may protect normal females against the risk of dofetilide-induced arrhythmia.
Revised on July 10, 2002
Accepted on July 19, 2002
Testosterone Diminishes the Proarrhythmic Effects
of Dofetilide in Normal Female Rabbits
Thai V. Pham PhD,
-dihydrotestosterone (DHT) protects normal females against drug-induced excessive prolongation of repolarization.
APD90=8±7 and 29±5 ms, respectively, P<0.05). At 10-6 mol/L dofetilide, the incidence of early afterdepolarizations was 28% in DHT-treated and 55% in normal female rabbits (P<0.05).
Key words: arrhythmia • sex • dofetilide • hormones
This article has been cited by other articles:
 |
|
 |
|
  L. Xiao, L. Zhang, W. Han, Z. Wang, and S. Nattel Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H570 - H580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-X. Bai, J. Kurokawa, M. Tamagawa, H. Nakaya, and T. Furukawa Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone Circulation, September 20, 2005; 112(12): 1701 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brouillette, K. Rivard, E. Lizotte, and C. Fiset Sex and strain differences in adult mouse cardiac repolarization: importance of androgens Cardiovasc Res, January 1, 2005; 65(1): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Roden Drug-Induced Prolongation of the QT Interval N. Engl. J. Med., March 4, 2004; 350(10): 1013 - 1022. [Full Text] [PDF]
|
|
|
|
|
|
T. V Pham Gender differences in cardiac development: are hormones at the heart of the matter? Cardiovasc Res, March 1, 2003; 57(3): 591 - 593. [Full Text] [PDF]
|
|